Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Treatment of luteal phase defects in assisted reproduction.

Muñoz E, Taboas E, Portela S, Aguilar J, Fernandez I, Muñoz L, Bosch E.

Curr Drug Targets. 2013 Jul;14(8):832-42. Review.

PMID:
23621507
2.

Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.

Krause BT, Ohlinger R.

Eur J Obstet Gynecol Reprod Biol. 2006 May 1;126(1):87-92. Epub 2005 Dec 22.

PMID:
16377065
3.

Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.

Andersen CY, Elbaek HO, Alsbjerg B, Laursen RJ, Povlsen BB, Thomsen L, Humaidan P.

Hum Reprod. 2015 Oct;30(10):2387-95. doi: 10.1093/humrep/dev184. Epub 2015 Jul 23.

PMID:
26209535
4.
5.

WITHDRAWN: Luteal phase support in assisted reproduction cycles.

Daya S, Gunby JL.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD004830. doi: 10.1002/14651858.CD004830.pub2. Review.

PMID:
18646113
6.

Luteal phase support in assisted reproduction cycles.

Daya S, Gunby J.

Cochrane Database Syst Rev. 2004;(3):CD004830. Review. Update in: Cochrane Database Syst Rev. 2008;(3):CD004830.

PMID:
15266541
7.

A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.

Liang IT, Huang HY, Wu HM, Wang HS, Yu HT, Huang SY, Chang CL, Soong YK.

Taiwan J Obstet Gynecol. 2015 Oct;54(5):583-7. doi: 10.1016/j.tjog.2015.08.012.

8.

Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.

Araujo E Jr, Bernardini L, Frederick JL, Asch RH, Balmaceda JP.

J Assist Reprod Genet. 1994 Feb;11(2):74-8.

PMID:
7819706
9.

Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles.

Peñarrubia J, Balasch J, Fábregues F, Creus M, Casamitjana R, Ballescá JL, Puerto B, Vanrell JA.

Hum Reprod. 1998 Dec;13(12):3315-8.

PMID:
9886506
10.

Luteal phase support for assisted reproduction cycles.

van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M.

Cochrane Database Syst Rev. 2015 Jul 7;(7):CD009154. doi: 10.1002/14651858.CD009154.pub3. Review.

PMID:
26148507
11.

Luteal phase support for assisted reproduction cycles.

van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD009154. doi: 10.1002/14651858.CD009154.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;7:CD009154.

PMID:
21975790
12.

GnRHa to trigger final oocyte maturation: a time to reconsider.

Humaidan P, Papanikolaou EG, Tarlatzis BC.

Hum Reprod. 2009 Oct;24(10):2389-94. doi: 10.1093/humrep/dep246. Epub 2009 Jul 16. Review.

PMID:
19608565
13.

Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders.

Bar-Hava I, Mizrachi Y, Karfunkel-Doron D, Omer Y, Sheena L, Carmon N, Ben-David G.

Fertil Steril. 2016 Aug;106(2):330-3. doi: 10.1016/j.fertnstert.2016.04.004. Epub 2016 Apr 22.

PMID:
27114332
14.

Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.

Lainas GT, Kolibianakis EM, Sfontouris IA, Zorzovilis IZ, Petsas GK, Lainas TG, Tarlatzis BC.

Hum Reprod. 2013 Jul;28(7):1929-42. doi: 10.1093/humrep/det114. Epub 2013 Apr 26.

PMID:
23624582
15.

GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study.

Kol S, Humaidan P, Itskovitz-Eldor J.

Hum Reprod. 2011 Oct;26(10):2874-7. doi: 10.1093/humrep/der220. Epub 2011 Jul 21.

PMID:
21784738
16.

The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives.

Humaidan P, Papanikolaou EG, Kyrou D, Alsbjerg B, Polyzos NP, Devroey P, Fatemi HM.

Reprod Biomed Online. 2012 Feb;24(2):134-41. doi: 10.1016/j.rbmo.2011.11.001. Epub 2011 Nov 9. Review.

PMID:
22197130
17.

Luteal phase defects in assisted reproduction: the role of luteal phase supplementation.

Capitanio GL, Ubaldi F, Giannini P, Croce S.

Acta Eur Fertil. 1992 Jan-Feb;23(1):15-9. Review.

PMID:
1293894
18.

Luteal phase support in assisted reproductive technology.

Pabuccu R, Akar ME.

Curr Opin Obstet Gynecol. 2005 Jun;17(3):277-81. Review.

PMID:
15870562
19.

Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.

Iliodromiti S, Blockeel C, Tremellen KP, Fleming R, Tournaye H, Humaidan P, Nelson SM.

Hum Reprod. 2013 Sep;28(9):2529-36. doi: 10.1093/humrep/det304. Epub 2013 Jul 19.

PMID:
23873146
20.

Supplemental Content

Support Center